Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jumei Yang

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
RMD Open|February 15, 2026
Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transitionJumei Yang, Hui Chai, Jiarui Zhu, et al.
Inflammation|December 17, 2024
Colchicine Alleviates Interstitial Lung Disease in an Experimental Autoimmune Myositis Murine Model by Inhibiting the Formation of Neutrophil Extracellular TrapsFeifei Li, Peipei Zhao, Liangtao Zhao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 9, 2026
High-throughput screened kaempferitrin potentiates trastuzumab efficacy in HER2-positive gastric cancer by targeting Cyclooxygenase-2 to inhibit ERK signalingHuiming Zhao, Jumei Yang, Hongwei Yu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2025
Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a potential therapeutic targetJumei Yang, Wenjun Li, Jiarui Zhu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
RMD Open|February 15, 2026
Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transitionJumei Yang, Hui Chai, Jiarui Zhu, et al.
Inflammation|December 17, 2024
Colchicine Alleviates Interstitial Lung Disease in an Experimental Autoimmune Myositis Murine Model by Inhibiting the Formation of Neutrophil Extracellular TrapsFeifei Li, Peipei Zhao, Liangtao Zhao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 9, 2026
High-throughput screened kaempferitrin potentiates trastuzumab efficacy in HER2-positive gastric cancer by targeting Cyclooxygenase-2 to inhibit ERK signalingHuiming Zhao, Jumei Yang, Hongwei Yu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2025
Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a potential therapeutic targetJumei Yang, Wenjun Li, Jiarui Zhu, et al.
Pageof 2